Insights Into Myelofibrosis (MF)

Perspectives on drivers in treatment decisions in the management of myelofibrosis (MF)

Gulf #1 – January 12, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Midwest #1 – January 18, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Northeast #1 – January 19, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Midwest #2 – January 25, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Northeast #2 – January 26, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Northeast #3 – February 2, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Ohio Valley – February 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

West #2 – February 16, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center

West #3 – February 23, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center

Ohio Valley #2 – March 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

Midwest #3 – March 15, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio

Ohio Valley #3 – March 30, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital

Gulf #2 – April 6, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Southeast #1 – April 7, 2022

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center

Gulf #3 – April 13, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center

Mid-Atlantic #1 – April 20, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Southeast #2 – April 27, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Mid-Atlantic #3 – May 3, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Mid-Atlantic #2 – May 4, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

Southeast #3 – May 18, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Southeast

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Southeast

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Southeast

Example Agenda

Export meeting topics

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of MF
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Current management and emerging challenges in MF
    • Current therapy paradigms for MF
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.